Table 2.
Demographic features of the patients
Donepezil (n = 19) | Rivastigmine (n = 17) | Galantamine (n = 19) | |
---|---|---|---|
Age, years | 78.4±6.5 | 77.2±5.4 | 77.4±6.0 |
Gender, men/women | 9/10 | 8/11 | 8/9 |
Length of education, years | 12.3±2.4 | 13.2±3.0 | 11.0±2.5 |
Duration of disease, years | 3.1±0.8 | 2.6±0.9 | 3.2±0.8 |
APOE ε4 carrier, n (%) | 10 (52.6) | 9 (52.9) | 9 (47.4) |
Duration of medication, months | 12.3±2.4 | 12.8±1.8 | 11.8±2.2 |
APOE = Apolipoprotein E.